Liu Guohui, E Mingyan
Department of Thoracic Radiation Therapy, Harbin Medical University Cancer Hospital, Harbin 150040, China.
Zhongguo Fei Ai Za Zhi. 2023 Jun 20;26(6):467-472. doi: 10.3779/j.issn.1009-3419.2023.106.11.
Radiation therapy is one of the main treatment methods for patients with thoracic malignant tumors, which can effectively improve the survival rate of the patients. However, radiation therapy can also cause damage to normal tissues while treating tumors, leading to radiation-induced lung injury such as radiation pneumonia and pulmonary fibrosis. Radiation-induced lung injury is a complex pathophysiological process involving many factors, and its prevention and treatment is one of the difficult problems in the field of radiation medicine. Therefore, the search for sensitive predictors of radiation-induced lung injury can guide clinical radiotherapy and reduce the incidence of radiation-induced lung injury. With the in-depth study of intestinal flora, it can drive immune cells or metabolites to reach lung tissue through the circulatory system to play a role, and participate in the occurrence, development and treatment of lung diseases. At present, there are few studies on intestinal flora and radiation-induced lung injury. Therefore, this paper will comprehensively elaborate the interaction between intestinal flora and radiation-induced lung injury, so as to provide a new direction and strategy for studying the protective effect of intestinal flora on radiation-induced lung injury. .
放射治疗是胸部恶性肿瘤患者的主要治疗方法之一,可有效提高患者的生存率。然而,放射治疗在治疗肿瘤的同时也会对正常组织造成损伤,导致放射性肺损伤,如放射性肺炎和肺纤维化。放射性肺损伤是一个涉及多种因素的复杂病理生理过程,其防治是放射医学领域的难题之一。因此,寻找放射性肺损伤的敏感预测指标可以指导临床放疗,降低放射性肺损伤的发生率。随着对肠道菌群研究的深入,其可驱动免疫细胞或代谢产物通过循环系统到达肺组织发挥作用,并参与肺部疾病的发生、发展及治疗。目前,关于肠道菌群与放射性肺损伤的研究较少。因此,本文将全面阐述肠道菌群与放射性肺损伤之间的相互作用,为研究肠道菌群对放射性肺损伤的保护作用提供新的方向和策略。